DOD Biotech PCL Stock

DOD Biotech PCL P/CF

The P/CF (Price-to-Cash-Flow Ratio) of DOD Biotech PCL (DOD.BK) as of Aug 12, 2026 is 8.80. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 23.08 — a change of -61.89% (lower).

P/CF

8.80

YoY

-61.89%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of DOD Biotech PCL is 2026 8.80 . P/CF (Price-to-Cash-Flow Ratio) of DOD Biotech PCL was 2025 23.08 . It decreases by -61.89% lower compared to the previous year.
Access this data via the Eulerpool API

DOD Biotech PCL Stock analysis

What does DOD Biotech PCL do? DOD Biotech PCL is a Thai biotechnology company specializing in the production of pharmaceuticals, diagnostics, and research products. Established in 2004, the company has become one of the most reputable biotechnology companies in Thailand. Its business model is based on the development and manufacturing of products used in medicine, veterinary medicine, and research. DOD Biotech PLC focuses on continually evolving and adapting its products to meet customer needs. Its main areas of focus are the production of pharmaceuticals, particularly anti-cancer drugs, diabetes medications, cardiovascular medications, and infection treatments. Additionally, the company manufactures diagnostics for disease early detection and precise diagnosis. It also offers a variety of products for research purposes. DOD Biotech PCL has partnerships with several companies in other countries, particularly in Asia and Europe. Its largest partner is the Indian company Sun Pharma, with which it has had a successful collaboration for many years. The company is known for its high-quality standards and is certified to ISO 9001:2015 and follows the Good Manufacturing Practices (GMP) required by the Thai FDA. DOD Biotech PCL has received international recognition, including the Frost & Sullivan Thailand Excellence Award and being recognized as a top 30 company in Thailand in 2020. Over the years, the company has built a loyal customer base that appreciates its high-quality products and excellent customer service. It has a strong online presence to better reach and serve its customers. In summary, DOD Biotech PCL is a leading biotechnology company in Thailand with a wide range of pharmaceuticals, diagnostics, and research products. It has earned an excellent reputation for its high-quality standards and top-notch customer service. With its strong online presence and partnerships with other companies in Asia and Europe, DOD Biotech PCL will undoubtedly remain an important player in the global healthcare market in the future. DOD Biotech PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DOD Biotech PCL stock

P/CF (Price-to-Cash-Flow Ratio) of DOD Biotech PCL is 8.80 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of DOD Biotech PCL changed from 23.08 to 8.80, representing a -61.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) DOD Biotech PCL since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s DOD Biotech PCL with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — DOD Biotech PCL

All Key Metrics — DOD Biotech PCL